Table 5.
Sensitivity (95% CrI) | φSE | Specificity (95% CrI) | φSP | |
---|---|---|---|---|
Clinical diagnosis | 81% (65, 95) | 85% (68, 95) | ||
Subchondral resorption | 67% (50, 88) | 0.09 (0.0, 0.17) | 86% (23, 99) | 0.02 (–0.05, 0.14) |
BME | 41% (28, 61) | 0.06 (–0.01, 0.12) | 92% (32, 100) | 0.02 (–0.04, 0.14) |
Erosion | 52% (37, 72) | 0.08 (0.00, 0.14) | 92% (32, 100) | 0.02 (–0.03, 0.14) |
Ankylosis | 6% (1, 14) | 0.00 (–0.04, 0.02) | 92% (29, 100) | 0.02 (–0.04, 0.12) |
BME, erosion, or ankylosis | 53% (38, 73) | 0.08 (0.01, 0.15) | 92% (34, 100) | 0.02 (–0.03, 0.14) |
BLCM Bayesian latent class model, CrI credible interval, φSE covariance between sensitivities of clinical diagnosis and MR feature, φSP covariance between specificities of clinical diagnosis and MR feature, MR magnetic resonance, BME bone marrow edema.